New York State Common Retirement Fund’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.9K Hold
13,100
﹤0.01% 3019
2026
Q1
$100K Sell
13,100
-44,625
-77% -$414K ﹤0.01% 2523
2025
Q4
$653K Buy
57,725
+44,625
+341% +$454K ﹤0.01% 1864
2025
Q3
$121K Hold
13,100
﹤0.01% 2532
2025
Q2
$90.1K Hold
13,100
﹤0.01% 2750
2025
Q1
$37.7K Hold
13,100
﹤0.01% 2859
2024
Q4
$61.6K Hold
13,100
﹤0.01% 2794
2024
Q3
$46.8K Sell
13,100
-12,000
-48% -$89K ﹤0.01% 2885
2024
Q2
$156K Buy
+25,100
New +$190K ﹤0.01% 2541
2023
Q3
Sell
-376
Closed -$1.24K 3305
2023
Q2
$1.24K Sell
376
-15,467
-98% -$45.4K ﹤0.01% 3302
2023
Q1
$45.2K Sell
15,843
-2,821
-15% -$25.3K ﹤0.01% 3007
2022
Q4
$136K Buy
18,664
+4
+0% +$26 ﹤0.01% 2872
2022
Q3
$151K Buy
18,660
+105
+0.6% +$752 ﹤0.01% 2877
2022
Q2
$91K Sell
18,555
-46
-0.2% -$450 ﹤0.01% 3100
2022
Q1
$440K Buy
18,601
+16
+0.1% +$226 ﹤0.01% 2463
2021
Q4
$329K Sell
18,585
-13
-0.1% -$258 ﹤0.01% 2659
2021
Q3
$525K Buy
18,598
+6,188
+50% +$117K ﹤0.01% 2441
2021
Q2
$130K Buy
12,410
+143
+1% +$1.45K ﹤0.01% 3162
2021
Q1
$145K Hold
12,267
﹤0.01% 2947
2020
Q4
$144K Hold
12,267
﹤0.01% 2872
2020
Q3
$97K Hold
12,267
﹤0.01% 2933
2020
Q2
$224K Buy
12,267
+6,500
+113% +$102K ﹤0.01% 2588
2020
Q1
$69K Hold
5,767
﹤0.01% 2894
2019
Q4
$96K Hold
5,767
﹤0.01% 3020
2019
Q3
$38K Buy
+5,767
New +$63.8K ﹤0.01% 3176

Other funds holding FULC

New York State Common Retirement Fund's FULC Position: Q2 2026 in Review

New York State Common Retirement Fund held its Fulcrum Therapeutics (FULC) position steady in Q2 2026 at 13,100 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

New York State Common Retirement Fund first reported a position in FULC in Q3 2019 and has held it in 25 quarters since. The position peaked at $653K in Q4 2025. 29 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • New York State Common Retirement Fund held 13,100 shares of Fulcrum Therapeutics worth $47.9K as of Q2 2026.
  • New York State Common Retirement Fund left its Fulcrum Therapeutics share count unchanged in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3019 holding.
  • New York State Common Retirement Fund first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's Fulcrum Therapeutics position peaked at $653K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.